You have 9 free searches left this month | for more free features.

PANC

Showing 1 - 25 of 118

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advances in Imaging to Assess Response in Pancreatic Cancer

Recruiting
  • Pancreatic Ductal Adenocarcinoma
    • Glasgow, United Kingdom
      Beatson West of Scotland Cancer Centre
    Feb 3, 2023

    Pancreatic Cancer Non-resectable Trial (collection of blood and tumor samples)

    Not yet recruiting
    • Pancreatic Cancer Non-resectable
    • collection of blood and tumor samples
    • (no location specified)
    Mar 27, 2023

    Determining Individualized Cancer Therapy in Pancreatic Cancer

    Not yet recruiting
    • Pancreatic Neoplasms
    • Targeted Therapy
    • Milwaukee, Wisconsin
      Froedtert Hospital and the Medical College of Wisconsin
    Jun 14, 2023

    Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jan 3, 2023

    Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

    Active, not recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Jan 5, 2023

    Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)

    Recruiting
    • Pancreatic Cyst
    • +7 more
    • Survey
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2022

    Panc CA Risk Model & Biomarker Testing In High-Risk Cohort

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Blood Specimen
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Sep 5, 2022

    Pancreatic Cancer Trial in United States (Niraparib Treatment)

    Recruiting
    • Pancreatic Cancer
    • Niraparib Treatment
    • Fairway, Kansas
    • +5 more
    May 17, 2022

    Cancer Cachexia in Subjects With Panc Adenocarcinoma

    Recruiting
    • Pancreas Adenocarcinoma
    • Cachexia
      • Charlotte, North Carolina
        Levine Cancer Institute
      Jun 17, 2022

      Pancreatic Cancer Trial in Baltimore (PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.)

      Recruiting
      • Pancreatic Cancer
      • PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Mar 3, 2022

      Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +2 more
      • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
      • Montpellier, France
        CHU Montpellier
      Jul 1, 2022

      Pancreatic Cancer Trial in Baltimore, Milwaukee (Cyclophosphamide, Nivolumab, GVAX Pancreas Vaccine)

      Active, not recruiting
      • Pancreatic Cancer
      • Baltimore, Maryland
      • +1 more
      Mar 3, 2022

      Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)

      Active, not recruiting
      • Pancreatic Cancer
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Mar 3, 2022

      Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body

      Recruiting
      • Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
      • Pancreatic Ductal Adenocarcinoma
      • Stereotactic Body Radiation (SBRT)
      • +3 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center
      Jan 28, 2022

      Resected Pancreatic Adenocarcinoma Trial in Washington (mFOLFIRINOX, Proton beam radiation)

      Recruiting
      • Resected Pancreatic Adenocarcinoma
      • Washington, District of Columbia
        Georgetown University Medical Center - Lombardi Comprehensive Ca
      Jul 27, 2021

      Cardiopulmonary Exercise Testing: An Assessment of Patients

      Not yet recruiting
      • Pancreatic Cancer
      • Cardiopulmonary Exercise Test
      • (no location specified)
      Jan 4, 2021

      Previously Treated Metastatic Adenocarcinoma of the Pancreas Trial in United States (CRS-207, nivolumab, GVAX)

      Completed
      • Previously Treated Metastatic Adenocarcinoma of the Pancreas
      • CRS-207
      • +3 more
      • San Francisco, California
      • +4 more
      Mar 17, 2021

      Pancreatic Cancer Trial in Gainesville, Tallahassee (TAS-102)

      Terminated
      • Pancreatic Cancer
      • Gainesville, Florida
      • +2 more
      Jan 13, 2021

      Metastatic Pancreatic Adenocarcinoma Trial in San Francisco, Baltimore, Saint Louis (Ipilimumab, Vaccine, FOLFIRINOX)

      Completed
      • Metastatic Pancreatic Adenocarcinoma
      • San Francisco, California
      • +2 more
      May 5, 2020

      Pancreatic Cancer Trial in Baltimore (Cetuximab, Pancreatic tumor vaccine, Cyclophosphamide)

      Completed
      • Pancreatic Cancer
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Feb 10, 2020

      Pancreatic Cancer Trial in Baltimore (Ipilimumab, Pancreatic Cancer Vaccine)

      Completed
      • Pancreatic Cancer
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Feb 20, 2020

      Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

      Not yet recruiting
      • Solid Tumor, Adult
      • +19 more
      • A2B694
      • xT CDx with HLA-LOH Assay
      • Duarte, California
      • +9 more
      Sep 22, 2023

      Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

      Not yet recruiting
      • Solid Tumor, Adult
      • +15 more
      • A2B530
      • xT-Onco with HLA-LOH Assay
      • Duarte, California
      • +6 more
      Feb 10, 2023

      Predict Lymphovascular Invasion in Pancreatic Ductal

      Recruiting
      • Predictive Cancer Model
      • Pancreas Cancer
        • Tianjin, Tianjin, China
          Tianjin Medical University Cancer Institute and Hospital
        Aug 10, 2023

        PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (Register)

        Recruiting
        • PDAC - Pancreatic Ductal Adenocarcinoma
        • Register
        • Verona, Italy
          AOUI Verona
        May 3, 2023